A lot of people from poor nations do not have enough money to pay for the medicine that can cure their diseases. While some may argue that pharmaceutical companies should offer discounts to these poor people so that they can access treatment, I do not believe this can remedy the situation because these drug companies should run their business instead of sharing the responsibility to ensure drug accessibility to everyone. In addition, people will still have the financial burden often due to prolonged treatment courses.Reduced price level generates lower revenue, which can push down the research and development spending by the pharmaceutical companies, resulting in fewer drugs reaching the market and eventually exacerbating drug scarcity. In other words, offering a lower drug cost to residents of less affluent countries will not reduce their death rate from curable diseases because it is not the business of pharmaceutical companies to ensure people can obtain their medicine, but In...